Frequency and clinical correlates of elevated plasma Epstein‐Barr virus DNA at diagnosis in peripheral T‐cell lymphomas-Reference-Cited by-同舟云学术

Frequency and clinical correlates of elevated plasma Epstein‐Barr virus DNA at diagnosis in peripheral T‐cell lymphomas

Published:2017-02-23 Issue:8 Volume:140 Page:1899-1906
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Haverkos Bradley M.¹,Huang Ying²,Gru Alejandro³,Pancholi Preeti⁴,Freud Aharon G.⁴⁵,Mishra Anjali⁵,Ruppert Amy S.²,Baiocchi Robert A.²⁵,Porcu Pierluigi²⁵

Affiliation:

1. Division of HematologyUniversity of ColoradoAurora CO

2. Division of HematologyThe Ohio State UniversityColumbus OH

3. Department of PathologyUniversity of VirginiaCharlottesville VA

4. Department of PathologyThe Ohio State UniversityColumbus OH

5. Comprehensive Cancer Center and The James Cancer Hospital and Solove Research Institute, The Ohio State UniversityColumbus OH

Funder

Pelotonia Idea Grant and philanthropic funding

NIH/NCI T32

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.30566

Reference46 articles.

1. International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes

2. Epstein‐Barr virus genome in non‐Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T‐cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO;d'Amore F;Blood,1996

3. Epstein-Barr virus–associated lymphoproliferative disorders

4. Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins

5. Experimental treatment of Epstein‐Barr virus‐associated primary central nervous system lymphoma;Roychowdhury S;Cancer Res,2003

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of plasma EBV-DNA load and EBER status on newly diagnosed peripheral T-cell lymphoma;Journal of Cancer Research and Clinical Oncology;2024-04-08

2. Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study;Blood Advances;2023-10-16

3. Front-line Chemo-immunotherapy with Nivolumab and Dose-Adjusted (DA) EPOCH in Peripheral T-cell Lymphoma: A Phase I Trial;2023-08-23

4. Circulating tumor DNA in NK/T and peripheral T cell lymphoma;Seminars in Hematology;2023-07

5. Utility of Epstein-Barr Viral Load in Blood for Diagnosing and Predicting Prognosis of Lymphoma;The Journal of Molecular Diagnostics;2022-09